Erratum to The effect of photon energy on intensity-modulated radiation therapy (IMRT) plans for prostate cancer (Radiat Oncol J, (2012), 30, (27-35), http://dx.doi.org/10.3857/roj.2012.30.1.27);The effect of photon energy on intensity-modulated radiation therapy (IMRT) plans for prostate cancer

Radiation Oncology Journal

Volumn 30, Issue 1, 2012, Pages 27-35

  Sung, Wonmo ^a,b   Park, Jong Min ^a,b   Choi, Chang Heon ^a,c   Ha, Sung Whan ^a,b   Ye, Sung Joon ^a,b,d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Veterans Health Service Medical Center   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Integral dose; Intensity modulated radiation therapy; Photon energy; Prostate cancer; Treatment planning

Indexed keywords

EID: 84867516583     PISSN: 22341900     EISSN: 22343164     Source Type: Journal    
DOI: 10.3857/roj.2012.30.2.96     Document Type: Erratum

References (19)

1. Howell RM, Hertel NE, Wang Z, Hutchinson J, Fullerton GD. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys 2006;33:360-8.
2. Welsh JS, Mackie TR, Limmer JP. High-energy photons in IMRT: uncertainties and risks for questionable gain. Technol Cancer Res Treat 2007;6:147-9.
3. Followill DS, Nusslin F, Orton CG. Point/counterpoint: IMRT should not be administered at photon energies greater than 10 MV. Med Phys 2007;34:1877-9.
4. Park JM, Choi CH, Ha SW, Ye SJ. The dosimetric effect of mixed-energy IMRT plans for prostate cancer. J Appl Clin Med Phys 2011;12:3563.
5. Park JM, Kim JI, Choi CH, Chie EK, Kim IH, Ye SJ. Photon energy-modulated radiotherapy: Monte Carlo simulation and treatment planning study. Med Phys 2012;39:1265-77.
6. Pirzkall A, Carol MP, Pickett B, Xia P, Roach M 3rd, Verhey LJ. The effect of beam energy and number of fi elds on photonbased IMRT for deep-seated targets. Int J Radiat Oncol Biol Phys 2002;53:434-42.
7. Chung JB, Kim JS, Kim IA, Lee JW, Cho W, Suh TS. The effect of photon energy on the intensity-modulated radiation therapy plan for prostate cancer: a planning study. J Korean Phys Soc 2011;59:183-8.
8. Li S, Boyer A, Lu Y, Chen GT. Analysis of the dose-surface histogram and dose-wall histogram for the rectum and bladder. Med Phys 1997;24:1107-16.
9. Ezzell GA, Schild SE, Wong WW. Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy. J Appl Clin Med Phys 2001;2:59-68.
10. Mott JH, Livsey JE, Logue JP. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol. Br J Radiol 2004;77:377-86.
11. Soderstrom S, Eklof A, Brahme A. Aspects on the optimal photon beam energy for radiation therapy. Acta Oncol 1999;38:179-87.
12. Ost P, Speleers B, De Meerleer G, et al. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study. Int J Radiat Oncol Biol Phys 2011;79:920-6.
13. Thangavelu S, Jayakumar S, Govindarajan KN, Supe SS, Nagarajan V, Nagarajan M. Influence of photon energy on the quality of prostate intensity modulated radiation therapy plans based on analysis of physical indices. J Med Phys 2011;36:29-34.
14. De Meerleer GO, Vakaet LA, De Gersem WR, De Wagter C, De Naeyer B, De Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000;47:639-48.
15. Lawton CA, Michalski J, El-Naqa I, et al. RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:383-7.
16. Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;62:1195-203.
17. Kry SF, Salehpour M, Followill DS, et al. Out-of-fi eld photon and neutron dose equivalents from step-and-shoot intensitymodulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;62:1204-16.
18. Kry SF, Salehpour M, Titt U, White RA, Stovall M, Followill D. Monte Carlo study shows no signifi cant difference in second cancer risk between 6-and 18-MV intensity-modulated radiation therapy. Radiother Oncol 2009;91:132-7.
19. Hussein M, Aldridge S, Guerrero Urbano T, Nisbet A. The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies. Br J Radiol 2012;85:423-32.